3 days popular7 days popular1 month popular3 months popular

DART protein shows potential as shock-and-kill strategy against HIV

A unique molecule developed at Duke Medicine, the University of North Carolina at Chapel Hill and MacroGenics, Inc., is able to bind HIV-infected cells to the immune system’s killer T cells. It could become a key part of a shock-and-kill strategy being developed in the hope of one day clearing HIV infection.

DART
This is a schematic representation of HIV DART binding to two distinct antigens simultaneously, redirecting the killer T cells to destroy HIV-1 infected cells.
Credit: Duke Medicine